Gissel, C., Götz, G., & Repp, H. (2017). Reply to: Need for improvements in reported cost-effectiveness of adalimumab in rheumatoid arthritis. Z Rheumatol.
Chicago Stili AlıntıGissel, C., G. Götz, ve H. Repp. "Reply To: Need for Improvements in Reported Cost-effectiveness Of adalimumab in Rheumatoid Arthritis." Z Rheumatol 2017.
MLA AlıntıGissel, C., G. Götz, ve H. Repp. "Reply To: Need for Improvements in Reported Cost-effectiveness Of adalimumab in Rheumatoid Arthritis." Z Rheumatol 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..